Corcept Therapeutics | صافي الدخل

Created with Highcharts 10.1.0Chart context menu13.4M18.8M25.1M31.3M37.6M43.9M49.3M
2022Q32023Q32024Q3


Net Income تغيير تاريخ
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
Alaunos Therapeutics USD -1127000 2K 2024-09
ANI Pharmaceuticals USD -10276000 13.89M 2024-12
Ardelyx USD 4.64M 5.45M 2024-12
Aurora Cannabis CAD 31.67M 43.71M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Canopy Growth CAD -121896000 6.4M 2024-12
Corcept Therapeutics USD 30.75M 16.47M 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
J&J USD 3.43B 737M 2024-12
Knight Therapeutics CAD 85K 2.03M 2024-09
Merck USD 3.74B 586M 2024-12
Novartis USD 2.82B 371M 2024-12
Novartis USD 2.82B 371M 2024-12
Pacira USD 16.04M 159.51M 2024-12
Pfizer USD 410M 4.06B 2024-12
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
TG Therapeutics USD 23.33M 19.45M 2024-12



Corcept Therapeutics صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.